Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

SSTR2 Protein-VLP

VLP SSTR2 protein expressed in HEK-293 Cells.
Catalog No. ABIN7199157

Quick Overview for SSTR2 Protein-VLP (ABIN7199157)

Target

See all SSTR2 Proteins
SSTR2 (Somatostatin Receptor 2 (SSTR2))

Protein Type

VLP

Origin

  • 13
  • 2
Human

Source

  • 8
  • 3
  • 2
  • 1
  • 1
HEK-293 Cells

Purity

>80 % as determined by SDS-PAGE.
  • Purpose

    Human SSTR2 Full Length Protein-VLP (HEK293)

    Sequence

    Met 1 - Ile 369

    Characteristics

    Human SSTR2 Full Length Protein-VLP is expressed from human 293 cells (HEK293). It contains AA Met 1 - Ile 369 (Accession # P30874-1).

    Endotoxin Level

    Less than 1.0 EU per μg by the LAL method.

    Components

    Virus-like particles(VLPs) are formed by self-assembly of envelop/capsid proteins from viruses. Membrance Proteins can be constituted in-situ with VLPs produced from HEK293 cell cultures. These VLPs concentrate conformationally intact membrane proteins directly on the cell surface and produce soluble, high-concentration proteins perfect for immunization and antibody screening.
    The VLPs provide the display of properly folded membrane proteins in their native cellular membrane in a compact size of 100~300 nm diameter (similar to the size of most viruses) making it optimal targets for dendritic cells in vivo and surface attachment for phage display.
  • Want other Options for this Protein ?

    !
    Discover Our Predefined Custom Proteins and Custom Protein Services!
    Product
    Expression System
    Conjugate
    Origin
    Price starts at
    Expression System HEK-293 Cells
    Conjugate His tag
    Origin Human
    Price starts at $16,231.82
    Expression System Cell-free protein synthesis (CFPS)
    Conjugate Strep Tag
    Origin Human
    Price starts at $20,480.57

    Your project requires further customization? Contact us and discover our custom protein solutions

  • Application Notes

    The protein has a calculated MW of 45.3 kDa.

    Comment

    Virus-like particles (VLPs) are formed by self-assembly of envelop/capsid proteins from viruses. Membrance Proteins can be constituted in-situ with VLPs produced from HEK293 cell cultures. These VLPs concentrate conformationally intact membrane proteins directly on the cell surface and produce soluble, high-concentration proteins perfect for immunization and antibody screening.
    The VLPs provide the display of properly folded membrane proteins in their native cellular membrane in a compact size of 100~300 nm diameter (similar to the size of most viruses) making it optimal targets for dendritic cells in vivo and surface attachment for phage display.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    PBS, pH 7.4

    Storage

    -80 °C

    Storage Comment

    -70°C
  • Target

    SSTR2 (Somatostatin Receptor 2 (SSTR2))

    Alternative Name

    SSTR2 Protein-VLP

    Background

    Synonyms: Smstr2,Somatostatin R2,somatostatin receptor 2,somatostatin receptor type 2,SomatostatinR2,SRIF-1,SS2R,SS-2-R,SS2-R,SST2,SSTR2,
    Somatostatin is a peptide with a potent and broad antisecretory action, which makes it an invaluable drug target for the pharmacological management of pituitary adenomas and neuroendocrine tumors. Somatostatin receptors (SSTR1, 2A and B, 3, 4 and 5) belong to the G protein coupled receptor family and have a wide expression pattern in both normal tissues and solid tumors. Investigating the function of each SSTR in several tumor types has provided a wealth of information about the common but also distinct signaling cascades that suppress tumor cell proliferation, survival and angiogenesis. This provided the rationale for developing multireceptor-targeted somatostatin analogs and combination therapies with signaling-targeted agents such as inhibitors of the mammalian (or mechanistic) target of rapamycin (mTOR). The ability of SSTR to internalize and the development of rabiolabeled somatostatin analogs have improved the diagnosis and treatment of neuroendocrine tumors.

    Molecular Weight

    45.3 kDa
You are here:
Chat with us!